Cargando…

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View

Clonal hematopoiesis of indeterminate potential (CHIP) is a common bone marrow abnormality induced by age‐related DNA mutations, which give rise to proinflammatory immune cells. These immune cells exacerbate atherosclerotic cardiovascular disease and may induce or accelerate heart failure. The mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikking, Maurits A., Stroeks, Sophie L. V. M., Waring, Olivia J., Henkens, Michiel T. H. M., Riksen, Niels P., Hoischen, Alexander, Heymans, Stephane R. B., Verdonschot, Job A. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492961/ https://www.ncbi.nlm.nih.gov/pubmed/37489738 http://dx.doi.org/10.1161/JAHA.123.030603

Ejemplares similares

Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy
por: Sikking, Maurits A., et al.
Publicado: (2023)

Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach
por: Verdonschot, Job A. J., et al.
Publicado: (2019)

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
por: Sella, Tal, et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity
por: Feldkamp, Jasper David, et al.
Publicado: (2022)

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
por: Huang, Yi-Chun, et al.
Publicado: (2021)

Clonal Hematopoiesis of Indeterminate Potential is Associated with Acute Kidney Injury
por: Vlasschaert, Caitlyn, et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
por: Hoermann, Gregor, et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19
por: Miller, Peter G., et al.
Publicado: (2022)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
por: Hoermann, Gregor
Publicado: (2022)

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
por: Komic, Luka, et al.
Publicado: (2023)

Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients
por: Swaminathan, Aparna C., et al.
Publicado: (2023)

Clustering of Cardiac Transcriptome Profiles Reveals Unique: Subgroups of Dilated Cardiomyopathy Patients
por: Verdonschot, Job A.J., et al.
Publicado: (2023)

Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential
por: Burns, Sarah S., et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
por: Senguttuvan, Nagendra Boopathy, et al.
Publicado: (2021)

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease
por: Uddin, M d Mesbah, et al.
Publicado: (2022)

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
por: Kuhnert, Stefan, et al.
Publicado: (2022)

Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19
por: Schenz, Judith, et al.
Publicado: (2022)

Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2022)

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
por: Schuermans, Art, et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
por: Burns, Sarah S., et al.
Publicado: (2020)

Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative
por: Haring, Bernhard, et al.
Publicado: (2021)

Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation
por: Goldman, Elisabeth A., et al.
Publicado: (2023)

Association of Clonal Hematopoiesis of Indeterminate Potential with Incident Heart Failure with Preserved Ejection Fraction
por: Reiner, Alex P., et al.
Publicado: (2023)

Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation
por: Park, Derek S., et al.
Publicado: (2019)

Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study
por: Denicolò, Sara, et al.
Publicado: (2022)

Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
por: Nakao, Tetsushi, et al.
Publicado: (2022)

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
por: Gagnon, Marie-France, et al.
Publicado: (2022)

Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
por: Bick, Alexander G., et al.
Publicado: (2022)

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
por: Li, Yong, et al.
Publicado: (2022)

P1642: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL ARE ASSOCIATED WITH INCREASED NETOSIS IN PATIENTS WITH CARDIOVASCULAR EVENTS
por: Marti, Severine, et al.
Publicado: (2023)

Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques
por: von Scheidt, Moritz, et al.
Publicado: (2023)

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022)

Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to atherlosclerotic cardio/cerebro-vascular diseases?
por: Li, Fei, et al.
Publicado: (2018)

Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential
por: Vela, Cory M., et al.
Publicado: (2018)

Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment
por: Yoshida, Reiko, et al.
Publicado: (2022)

Response to: “Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study”
por: Vlasschaert, Caitlyn, et al.
Publicado: (2022)

Coronary Microvascular Injury in Reperfused Acute Myocardial Infarction: A View From an Integrative Perspective
por: Sezer, Murat, et al.
Publicado: (2018)

Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Risk in Patients with Chronic Kidney Disease without Previous Cardiac Pathology
por: Kislikova, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bl8aqu34dh24n00smasrfcg1fj